What is the preparation and dosing for an aminophylline (theophylline) drip in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aminophylline Drip Preparation and Dosing in Pediatric Patients

For pediatric patients requiring aminophylline (theophylline) administration, prepare the drip by adding the calculated dose to D5W at a concentration not exceeding 2 mg/mL, and administer according to age-specific dosing guidelines. 1

Preparation of Aminophylline Drip

  • Aminophylline should be diluted in D5W (5% dextrose in water) to a concentration not exceeding 2 mg/mL 1
  • The solution must be prepared under sterile conditions and should be used with an infusion pump for accurate delivery 2
  • Avoid mixing aminophylline with other medications in the same infusion line to prevent precipitation and compatibility issues 1

Loading Dose Considerations

  • For children who have not received theophylline in the past 24 hours: 6 mg/kg IV administered over 20-30 minutes 3
  • For children who have received theophylline within the past 24 hours: 3 mg/kg IV (half loading dose) to avoid toxicity 4
  • If a patient has taken sustained-release theophylline preparation within 24 hours, check serum levels before administering loading dose 4

Maintenance Infusion Dosing by Age Group

  • Neonates (premature): 4-6 mg/kg/day divided as continuous infusion (approximately 0.17-0.25 mg/kg/hour) 3
  • Infants 1-6 months: 0.5 mg/kg/hour (12 mg/kg/day) 5
  • Children 6 months to 1 year: 0.6-0.7 mg/kg/hour (14-17 mg/kg/day) 5
  • Children 1-9 years: 0.8-1.0 mg/kg/hour (19-24 mg/kg/day) 5
  • Children 9-16 years: 0.7-0.8 mg/kg/hour (17-19 mg/kg/day) 5

Monitoring and Dose Adjustments

  • Target therapeutic serum theophylline concentration: 10-15 μg/mL 6
  • Monitor serum theophylline levels 30 minutes after loading dose and then every 24 hours during continuous infusion 6
  • Reduce dose by approximately 40% in patients with concurrent upper respiratory tract infections as theophylline clearance is reduced 6
  • Adjust dosing based on serum levels, clinical response, and presence of side effects 1

Special Considerations

  • Children clear theophylline more rapidly than adults, requiring higher mg/kg dosing 5
  • Younger children (1-9 years) eliminate theophylline more rapidly than older children and may need higher doses 5
  • Patients with fever, liver dysfunction, or heart failure may require dose adjustments due to altered metabolism 6
  • Continuous cardiac monitoring is recommended during initiation of therapy 1

Potential Side Effects and Precautions

  • Common side effects include tachycardia, nausea, vomiting, and irritability 1
  • Serious toxicity can occur with serum levels >20 μg/mL, including seizures and cardiac arrhythmias 1
  • Use with caution in patients with cardiac disease, seizure disorders, or hepatic impairment 1
  • Avoid rapid infusion as it may cause hypotension and cardiac arrhythmias 1

Weaning Protocol

  • When transitioning to oral therapy, reduce IV dose by 50% when first oral dose is given 5
  • Consider switching to oral therapy once the patient can tolerate oral medications and clinical status has improved 5

Remember that aminophylline contains approximately 80% theophylline by weight, so dosing calculations must account for this when converting between the two medications 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Aminophylline loading in asthmatic patients: a protocol trial.

Annals of emergency medicine, 1989

Research

Are current pediatric dose recommendations for intravenous theophylline appropriate?

The Journal of asthma : official journal of the Association for the Care of Asthma, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.